Activation of the Tumor Suppressor PP2A Emerges as a Potential Therapeutic Strategy for Treating Prostate Cancer

Protein phosphatase 2A (PP2A) is a tumor suppressor complex that has recently been reported as a novel and highly relevant molecular target in prostate cancer (PCa). However, its potential therapeutic value remains to be fully clarified. We treated PC-3 and LNCaP cell lines with the PP2A activators...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ion Cristóbal, Paula González-Alonso, Lina Daoud, Esther Solano, Blanca Torrejón, Rebeca Manso, Juan Madoz-Gúrpide, Federico Rojo, Jesús García-Foncillas
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2015-05-01
Colecção:Marine Drugs
Assuntos:
p-PP2A
CIP2A
okadaic acid
prostate cancer
therapy
Acesso em linha:http://www.mdpi.com/1660-3397/13/6/3276
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados